主要文献
- 1）
- Kitamura M, et al.: J Bone Miner Res, 31（4）: 806-814, 2016
Masahiro Kitamura et al. Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.
Journal of Bone and Mineral Research (2016) vol. 31 no. 4 806-814 doi: 10.1002/jbmr.2738
(http://onlinelibrary.wiley.com/doi/10.1002/jbmr.2738/full)
©2015 Masahiro Kitamura et al; Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). - 2）
- Kitamura M, et al.: J Dental Res, 90（1）: 35-40, 2011
- 3）
- Anzai J, et al.: PLoS One 11（7）: e0158485, 2016
- 4）
- Nagayasu-Tanaka T, et al.: PLoS One 10（6）: e0131870, 2015
- 5）
- Okumura M, et al.: Arzneim-Forsch/Drug Res, 46（Ⅱ）, 7: 727-739, 1996
- 6）
- Hikaru Tanaka, et al.: Cancer Letters 105: 195-202, 1996
- 7）
- Satoshi Tsunoda, et al.: Cancer Science 98（4）: 541-548, 2007
